Surrozen (SRZN) EBT Margin (2024 - 2026)
Surrozen (SRZN) posted quarterly EBT Margin of 650.04% for Q1 2026, up 81029.0% year-over-year from N/an in Q1 2025, and up 62.08% quarter-over-quarter from 1714.2% in Q4 2025.
Surrozen (SRZN) EBT Margin (2024 - 2026) Analysis & Trends
Surrozen's EBT Margin history runs 3 years deep, the most recent figure standing at 650.04% for Q1 2026.
- In Q1 2026, EBT Margin rose 81029.0% year-over-year to 650.04%; the TTM figure through Mar 2026 stood at 1021.96% (down 29034.0% YoY), while the FY2025 annual figure was 1493.64%, down 78279.0% from the prior year.
- EBT Margin for Q1 2026 stood at 650.04%, up from 1714.2% in the prior quarter.
- The five-year high for EBT Margin was 1.04% in Q3 2024, with the low at 9175.73% in Q4 2024.
- The 3-year median for EBT Margin is 1710.68% (2025), against an average of 2366.16%.
- Peak annual rise in EBT Margin reached 746152 bps in 2025, while the deepest fall reached 185424 bps in 2025.
- Surrozen's EBT Margin stood at 9175.73% in 2024, then surged by 81 bps to 1714.2% in 2025, then soared by 62 bps to 650.04% in 2026.
- Business Quant data shows SRZN's EBT Margin at 650.04% in Q1 2026, 1714.2% in Q4 2025, and 1853.2% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 34.77% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 18.33% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -94.22% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.77% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -2.67% |
| 10 | Surrozen | 281.63 Mn | 281.63 Mn | - | -530.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -530.46% |
| Mar 31, 2026 | -650.04% |
| Dec 31, 2025 | -1,714.20% |
| Sep 30, 2025 | -1,853.20% |
| Jun 30, 2025 | -1,710.68% |
| Mar 31, 2025 | -1,460.33% |
| Dec 31, 2024 | -9,175.73% |
| Sep 30, 2024 | 1.04% |